Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesAmortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Cellebrite DI (CLBT) Share-based Compensation (IS): 2021-2023

Historic Share-based Compensation (IS) for Cellebrite DI (CLBT) over the last 3 years, with Dec 2023 value amounting to $19.0 million.

  • Cellebrite DI's Share-based Compensation (IS) rose 42.50% to $6.6 million in Q2 2024 from the same period last year, while for Jun 2024 it was $21.9 million, marking a year-over-year increase of 34.41%. This contributed to the annual value of $19.0 million for FY2023, which is 38.59% up from last year.
  • Per Cellebrite DI's latest filing, its Share-based Compensation (IS) stood at $19.0 million for FY2023, which was up 38.59% from $13.7 million recorded in FY2022.
  • In the past 5 years, Cellebrite DI's Share-based Compensation (IS) ranged from a high of $19.0 million in FY2023 and a low of $6.5 million during FY2021.
  • Moreover, its 3-year median value for Share-based Compensation (IS) was $13.7 million (2022), whereas its average is $13.1 million.
  • Data for Cellebrite DI's Share-based Compensation (IS) shows a peak YoY spiked of 111.54% (in 2022) over the last 5 years.
  • Cellebrite DI's Share-based Compensation (IS) (Yearly) stood at $6.5 million in 2021, then soared by 111.54% to $13.7 million in 2022, then surged by 38.59% to $19.0 million in 2023.